ShadowBuys
Committee overlap: Science

Rep. April McClain Delaney bought BWX Technologies (BWXT)

Rep. April McClain Delaney (D-MD-6) · $15K–$50K · traded May 8, 2026

Why this is a committee overlap

McClain Delaney is a member of the House Committee on Science, Space, and Technology, which oversees Aerospace & Defense companies. BWX Technologies is classified in the Aerospace & Defense industry.

An overlap is a fact about the trade, not evidence of wrongdoing. Committee assignments are current ones.

Transaction
Bought
Amount
$15K–$50K
Owner
Dependent
Traded
May 8, 2026
Disclosed
Jun 5, 2026
Days to disclose
28
Asset type
Stock
As filed
BWX Technologies, Inc. Common Stock
Industry
Aerospace & Defense · Industrials

Other trades in this filing

All of McClain Delaney's trades →

Recent Congress trades in BWXT

Company context for BWXT

Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.

  1. BWXTCompany announcement·SEC EDGAR

    BWXT: Other company developments

    Filed 8-K for an event or period dated 2026-11-04. Other company developments.

    Public: Nov 4, 2026, 4:05 PM ESTEvent / period: Nov 4, 2026Original source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

  2. BWXTCompany announcement·SEC EDGAR

    BWXT: Material agreement · New financial obligation

    Filed 8-K for an event or period dated 2026-11-03. Material agreement; New financial obligation.

    Public: Nov 3, 2026, 4:05 PM ESTEvent / period: Nov 3, 2026Original source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

  3. BWXTCompany announcement·SEC EDGAR

    BWXT: Financial results

    Filed 8-K for an event or period dated 2026-09-30. Financial results.

    Public: Nov 2, 2026, 4:15 PM ESTEvent / period: Sep 30, 2026Original source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.